Document is current

Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine

Crossref DOI link: https://doi.org/10.1007/s10549-014-3126-0

Published Online: 2014-09-13

Published Print: 2014-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy